Published by Iain Gilbert on 2nd March 2020
(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has acquired rights for the potential new use of AOC3 inhibitors covered by a recently filed patent application.
URL: http://www.digitallook.com/dl/news/story/30322339/...